TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  Benzinga

Novo Nordisk Will Soon Reveal Whether Its GLP-1 Drug Can Slow Alzheimer's

Benzinga Logo Benzinga By Vandana Singh
Novo Nordisk Will Soon Reveal Whether Its GLP-1 Drug Can Slow Alzheimer's

Novo Nordisk is set to present findings on December 3rd about its diabetes drug Rybelsus potentially slowing Alzheimer's progression. The late-stage studies aim to determine if the drug can reduce cognitive decline by at least 20% in patients with mild Alzheimer's.

Insights
META   negative

Noted as experiencing stock price decline in market movers section


NVO   positive

Potential breakthrough in Alzheimer's treatment with promising clinical trials of Rybelsus